Venture • Life Science

Andera Partners Invests In AgomAb Therapeutics

On October 10, 2019, private equity firm Andera Partners invested in life science company AgomAb Therapeutics

Investment Context
  • This is Andera Partners’ 21st transaction in the Life Science sector.
  • This is Andera Partners’ 6th transaction in Belgium.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date October 10, 2019
Target AgomAb Therapeutics
Sector Life Science
Investor(s) Andera Partners
Deal Type Venture

Target Company

AgomAb Therapeutics

Antwerpen, Belgium
AgomAb Therapeutics is a biotherapeutics company developing agonistic antibodies for the regeneration of damaged tissues. AgomAb Therapeutics was founded in 2017 and is based in Antwerpen, Belgium.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Andera Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 3.7B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.


Deal Context for Investor #
Overall 80 of 123
Sector: Life Science 21 of 27
Type: Venture 22 of 28
Country: Belgium 6 of 9
Year: 2019 12 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-01 Olaqin

Suresnes, France

Olaqin is a value-added e-health service operator that supports healthcare professionals through tailored solutions adapted to each sector. It delivers its services either indirectly or via a dedicated partner network. Olaqin was founded in 2019 and is based in Suresnes, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-15 Groupe Bacacier

Aigueperse, France

Groupe Bacacier is one of France’s major specialists in metal cladding. Drawing on high levels of industry expertise in the transformation of steel (profiling, folding, cutting, stamping and pressing), Bacacier provides a full range of cladding products (roofing, facades and cladding, structural floors and false ceilings). Groupe Bacacier products are used in all types of buildings: industrial, agricultural, commercial and residential. Bacacier has also expanded its offering of consumer products, available through major DIY chains, and developed a range for architects, notably in collaboration with designer Philippe Starck.

Sell -

Explore Related M&A Activity